摘要
There has been an increasing number of studies regarding the influence of body composition on the oncological outcomes of patients.Recent research demonstrated that sarcopenic obesity is associated with the occurrence,development and prognosis of carcinoma.An early diagnosis and effective therapy can improve cancer patients’clinical outcomes.As a consequence,understanding the effects of sarcopenic obesity is critical to better direct patient care.This review describes the relationship between sarcopenic obesity and adverse clinical outcomes in cancer patients.Higher dose-limited toxicity and surgical complications has been found among cancer patients with sarcopenia obesity,compared with normal population.More attention should be paid to sarcopenic obesity in these patients.
基金
the National Natural Science Foundation of China[No.81773238]
Zhongnan Hospital Foster Foundation[cxpy20160042].